A Critical Role for Granzyme B, in Addition to Perforin and TNF??, in Alloreactive CTL-Induced Mouse Pancreatic Beta Cell Death
- 27 January 2006
- journal article
- research article
- Published by Wolters Kluwer Health in Transplantation
- Vol. 81 (2) , 146-154
- https://doi.org/10.1097/01.tp.0000191939.68451.d9
Abstract
Background. The precise effector mechanisms and molecular mediators used by alloreactive cytotoxic T lymphocytes to kill transplanted pancreatic beta cells are poorly defined. We have used mouse (H2b-anti-d) CTLs raised in strains deficient in various key cytotoxic effector molecules to assess the importance of the various signaling pathways mobilized to kill primary mouse pancreatic islet cells, the beta cell line NIT-1, and NIT-1 cells overexpressing dominant-negative FADD and Bcl-2. Methods. Death of target cells was assessed using 51Cr release assays. Results. In short-term assays (<5 hours) beta cell death did not require a functional FasL/Fas pathway, and was not inhibited by Bcl-2. However, the absence of either perforin or granzyme B resulted in cell survival. By contrast, a crucial role for granzyme B was not seen when hematopoietic P815 cells were used as targets, indicating differential regulation of apoptosis. Interestingly, coincubation with CTL for 24 hours revealed an additional but less potent “late phase” of beta cell death that did not require perforin. This delayed death was blocked by dominant-negative FADD, but not by Bcl-2, and was likely to be due to TNFα secretion. Conclusions. This study suggests that strategies to protect beta cells from allogeneic CTL attack will need to inhibit the perforin/granzyme and probably also the TNFα pathway. As there are no known pharmacological approaches to blocking perforin, therapeutic approaches based on overexpressing both dominant negative FADD and an inhibitor of granzyme B may hold promise in prolonging beta cell survival in the allogeneic setting.Keywords
This publication has 43 references indexed in Scilit:
- Islet Transplantation as a Treatment for Diabetes — A Work in ProgressNew England Journal of Medicine, 2004
- Nature's TRAIL—On a Path to Cancer ImmunotherapyImmunity, 2003
- Functional significance of the perforin/granzyme cell death pathwayNature Reviews Immunology, 2002
- Perforin Gene Defects in Familial Hemophagocytic LymphohistiocytosisScience, 1999
- A20 Inhibits Cytokine-Induced Apoptosis and Nuclear Factor κB–Dependent Gene Activation in IsletsThe Journal of Experimental Medicine, 1999
- Local Expression of TNFα in Neonatal NOD Mice Promotes Diabetes by Enhancing Presentation of Islet AntigensImmunity, 1998
- ISLET REJECTION IN PERFORIN-DEFICIENT MICETransplantation, 1997
- Acute rejection of vascular heart allografts by perforin‐deficient miceEuropean Journal of Immunology, 1995
- Cytotoxicity mediated by T cells and natural killer cells is greatly impaired in perforin-deficient miceNature, 1994
- Fas involvement in Ca(2+)-independent T cell-mediated cytotoxicity.The Journal of Experimental Medicine, 1993